VIROLOGY RESEARCH SERVICES

VRS now offers validated antiviral and neutralisation assay services for Human Metapneumovirus (hMPV). hMPV is a leading cause of acute respiratory tract infections worldwide, particularly in young children, the elderly, and immunocompromised individuals. Despite its significant clinical burden, there are currently no approved vaccines or specific antiviral treatments. With growing interest in re…

Ancient Mesopotamian lawmakers wrote penalties for owners of rabid dogs around 1930 BC. In 1918, an influenza virus that likely originated in birds or pigs killed an estimated 50 million people, more than the combat deaths of World War I. In the 1920s, HIV-1 crossed from chimpanzees to humans in Central Africa through bushmeat hunting. […]

Every time you sneeze or cough during an infection, you may be doing exactly what the virus wants. While the immune system clears most infections, viruses have evolved ways to escape the respiratory tract and reach new hosts. They achieve this by altering airway neuronal control, enhancing reflexes that expel virus-laden droplets, and stimulating parasympathetic […]

VRS now offers antiviral testing services for alpha herpesviruses HSV-1 and HSV-2. Most people (60–65%) will be infected with HSV-1 over their lifetime, and HSV-2 infection is present in around 10–11%. Once considered little more than a benign nuisance, herpes simplex viruses are now implicated in conditions far beyond cold sores. Recent research links them […]

Regulatory testing requires data that’s traceable, defensible, and meets internationally recognized standards. For product claims and regulatory submissions, results need to be backed by documented technical competence. ISO 17025 is the international standard for testing and calibration laboratories. It’s about demonstrating technical competence, maintaining rigorous quality controls,…

Around 8% of the human genome consists of sequences derived from ancient retroviruses – infections that became permanently embedded in our ancestors’ DNA millions of years ago. Most of these have since degraded or been silenced. But some have been repurposed, co-opted by evolution to serve functions including placental development, gene regulation, and immune defence. […]

Strip a virus of its pathogenic genes, replace them with therapeutic ones, and you have a delivery system evolution spent millions of years perfecting. A single injection that rewrites cellular instructions to correct a genetic disease, target cancer, or prime immunity against infection; this is the promise of viral vector technology. Several approved therapies now […]

Viral RNA clears from the bloodstream, antibodies stabilize, yet symptoms continue. This persistence despite apparent viral clearance has challenged clinicians for decades. Recent research into viral reservoirs, immune dysregulation, and mitochondrial dysfunction is starting to provide answers. Historical Recognition of Post-Viral Illness The idea of post-viral symptoms is not recent. Nineteenth-…

A virus infected a microbe on a Tibetan glacier 40,000 years ago, then froze in place. When scientists thawed the ice in 2024, they sequenced that viral genome along with 1,704 others, and most bore no resemblance to known viruses. These ancient genetic archives are just one example of how metagenomics is reshaping our understanding […]

Virology Research Services Ltd. (VRS) and Advanced Virology Inc. have joined forces in a strategic partnership that combines VRS’s specialized testing capabilities with Advanced Virology’s engineered virus production. Together, they offer an integrated solution for customers working in virology R&D, product development, manufacturing, and QC testing worldwide. Virology Research Se…

Imagine you’re fighting a war, and your most feared enemy suddenly switches sides to fight alongside you. That’s exactly what’s happening in cancer research labs around the world, where scientists are turning our oldest microscopic adversaries – viruses – into targeted tools against tumors. Viruses can be considered the ultimate villains, agents of disease and […]

In January 2020, Chinese scientists uploaded the genetic sequence of a new coronavirus to a public database. Within days, AI algorithms were already predicting its protein structures, identifying potential drug targets, and helping design vaccine candidates. What once took years was happening in real-time. This is the new frontier of AI drug discovery in virology […]